球虫药市场：按类型、动物类型划分 - 全球预测 2024-2030

预计2023年球虫药市场规模为16.2亿美元，预计2024年将达17.6亿美元，2030年将达30.4亿美元，复合年增长率为9.39%。

全球球虫药市场

FPNV定位矩阵

FPNV定位矩阵对于评估球虫药市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以球虫药市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-球虫药市场的市场规模与预测是多少？

2-球虫药市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-球虫药市场的技术趋势和法律规范是什么？

4-球虫药市场主要供应商的市场占有率是多少？

5-进入球虫药市场的合适型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 牲畜球虫病率上升
    • 畜牧业实践持续改善
    • 增加政府投资改善动物福利
  • 抑制因素
    • 政府球虫药物的严格规定
  • 机会
    • 先进球虫药物的开发
    • 介绍製造商预防球虫的努力
  • 任务
    • 替代药物和治疗方法的可用性
• 市场区隔分析
• 市场趋势分析
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范

第六章球虫药市场：依类型

• 抗生素球虫药
• 化学衍生物球虫药
• 离子载体球虫剂

第七章球虫药市场：依动物类型

• 水产养殖
• 家畜
• 家禽

第八章 北美、南美球虫药市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太球虫药市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章 欧洲、中东和非洲抗球虫药市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争形势

• FPNV定位矩阵
• 市场占有率分析：主要企业
• 主要企业竞争情境分析

第12章竞争产品组合

• 主要公司简介
  • Bioproperties Pty Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cronus Pharma
  • Elanco Animal Health Inc.
  • Fengchen Group Co., Ltd.
  • Hipra Laboratories, SA
  • Huvepharma EOOD
  • Impextraco NV
  • Intas Pharmaceuticals Ltd.
  • Jurox Pty Limited
  • Kaken Pharmaceutical Co. Ltd.
  • Kemin Industries Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Phibro Animal Health Corporation
  • Qilu Animal Health Products Co., Ltd.
  • Salius Pharma Pvt. Ltd.
  • TOKU-E
  • VH Group
  • Virbac Group
  • VIVAN Life Sciences Pvt. Limited
  • Zoetis Inc.
• 主要产品系列

第十三章附录

• 讨论指南
• 关于许可证和定价

[185 Pages Report] The Anticoccidial Drugs Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.76 billion in 2024, at a CAGR 9.39% to reach USD 3.04 billion by 2030.

Global Anticoccidial Drugs Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticoccidial Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticoccidial Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticoccidial Drugs Market, highlighting leading vendors and their innovative profiles. These include Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Fengchen Group Co., Ltd., Hipra Laboratories, S.A., Huvepharma EOOD, Impextraco NV, Intas Pharmaceuticals Ltd., Jurox Pty Limited, Kaken Pharmaceutical Co. Ltd., Kemin Industries Inc., Merck & Co., Inc., Novartis AG, Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Salius Pharma Pvt. Ltd., TOKU-E, VH Group, Virbac Group, VIVAN Life Sciences Pvt. Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoccidial Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Antibiotic Anticoccidials
  • Chemical Derivative Anticoccidials
  • Ionophore Anticoccidials
• Animal Type
  • Aquaculture
  • Livestock
  • Poultry
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anticoccidial Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticoccidial Drugs Market?

3. What are the technology trends and regulatory frameworks in the Anticoccidial Drugs Market?

4. What is the market share of the leading vendors in the Anticoccidial Drugs Market?

5. Which modes and strategic moves are suitable for entering the Anticoccidial Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Anticoccidial Drugs Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of coccidiosis in livestock
    • 5.1.1.2. Growing improvements in animal husbandry practices
    • 5.1.1.3. Increasing government investments in improving animal welfare
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent government regulations for anticoccidial drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of advanced anticoccidial drugs
    • 5.1.3.2. Introduction of coccidiosis management initiatives by manufacturers
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative medicines and treatments
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Anticoccidial Drugs Market, by Type

• 6.1. Introduction
• 6.2. Antibiotic Anticoccidials
• 6.3. Chemical Derivative Anticoccidials
• 6.4. Ionophore Anticoccidials

7. Anticoccidial Drugs Market, by Animal Type

• 7.1. Introduction
• 7.2. Aquaculture
• 7.3. Livestock
• 7.4. Poultry

8. Americas Anticoccidial Drugs Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Anticoccidial Drugs Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Anticoccidial Drugs Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Bioproperties Pty Ltd.
  • 12.1.2. Boehringer Ingelheim International GmbH
  • 12.1.3. Ceva Sante Animale
  • 12.1.4. Cronus Pharma
  • 12.1.5. Elanco Animal Health Inc.
  • 12.1.6. Fengchen Group Co., Ltd.
  • 12.1.7. Hipra Laboratories, S.A.
  • 12.1.8. Huvepharma EOOD
  • 12.1.9. Impextraco NV
  • 12.1.10. Intas Pharmaceuticals Ltd.
  • 12.1.11. Jurox Pty Limited
  • 12.1.12. Kaken Pharmaceutical Co. Ltd.
  • 12.1.13. Kemin Industries Inc.
  • 12.1.14. Merck & Co., Inc.
  • 12.1.15. Novartis AG
  • 12.1.16. Phibro Animal Health Corporation
  • 12.1.17. Qilu Animal Health Products Co., Ltd.
  • 12.1.18. Salius Pharma Pvt. Ltd.
  • 12.1.19. TOKU-E
  • 12.1.20. VH Group
  • 12.1.21. Virbac Group
  • 12.1.22. VIVAN Life Sciences Pvt. Limited
  • 12.1.23. Zoetis Inc.
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ANTICOCCIDIAL DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ANTICOCCIDIAL DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ANTICOCCIDIAL DRUGS MARKET DYNAMICS
• FIGURE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 6. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANTIBIOTIC ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY CHEMICAL DERIVATIVE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 100. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. ANTICOCCIDIAL DRUGS MARKET LICENSE & PRICING